Literature DB >> 1458469

Clonal growth of hepatitis B virus-integrated hepatocytes in cirrhotic liver nodules.

H Yasui1, O Hino, K Ohtake, R Machinami, T Kitagawa.   

Abstract

A total of 83 cirrhotic nodules (pseudolobules) individually collected from 11 cirrhotic livers of hepatitis B virus carrier patient were analyzed for the frequency and mode of hepatitis B virus integration as well as histological features. Southern blot analysis disclosed discrete bands at higher molecular weight region in 26 of 83 nodules (31.3%), indicating a clonal growth of hepatocytes with viral integration. Considerable variation (0-75%) existed in the positive rates for discrete bands in nodules among livers. Molecular cloning revealed the sequence flanking an integrated viral sequence to be host DNA and thus confirmed true integration. Histological analysis, however, did not reveal any neoplastic-appearing foci of growth within nodules, despite the fact that the detection sensitivity would predict clones of more than 10(5) cells to give rise to clonal integration patterns on Southern blot analysis. The question of whether clonal expansion of hepatocytes reflects any viral integration-associated growth advantage and/or a preneoplastic condition awaits future studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458469

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration.

Authors:  Colin A Bill; Jesse Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-16       Impact factor: 11.205

3.  Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis.

Authors:  T Yamada; A T De Souza; S Finkelstein; R L Jirtle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

Review 4.  Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

Authors:  Yujin Hoshida; Bryan C Fuchs; Kenneth K Tanabe
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

5.  Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection.

Authors:  William S Mason; Allison R Jilbert; Jesse Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

6.  Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration.

Authors:  José L Rodríguez; Juan Sandoval; Gaetano Serviddio; Juan Sastre; María Morante; Maria-Giulia Perrelli; María L Martínez-Chantar; José Viña; Juan R Viña; José M Mato; Matías A Avila; Luis Franco; Gerardo López-Rodas; Luis Torres
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

Review 7.  Hepatocarcinogenesis in rodents and humans.

Authors:  T Kitagawa; K Miyasaka; H Kanda; H Yasui; O Hino
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

8.  Hepatitis B virus infection associated with hematopoietic tumors.

Authors:  E Galun; Y Ilan; N Livni; M Ketzinel; O Nahor; G Pizov; A Nagler; A Eid; A Rivkind; M Laster
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

9.  Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection.

Authors:  William S Mason; Huey-Chi Low; Chunxiao Xu; Carol E Aldrich; Catherine A Scougall; Arend Grosse; Andrew Clouston; Deborah Chavez; Samuel Litwin; Suraj Peri; Allison R Jilbert; Robert E Lanford
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

10.  Overexpression of DNA methyltransferase 1 and its biological significance in primary hepatocellular carcinoma.

Authors:  Hong Fan; Zhu-Jiang Zhao; Jian Cheng; Xian-Wei Su; Qing-Xiang Wu; Yun-Feng Shan
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.